SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS ARTICLE H impact

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 4, 2026

For best results when printing this announcement, please click on link below: Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 4, 2026 Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter financial and operating results after the market close on Wednesday, November 4, 2026, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET. To participate in the conference call by telephone, dial 1-800-343-4849 or 1-203-518-9848 and reference Maravai LifeSciences, Conference ID: MARAVAI. The call will also be available via live or archived webcast on the "Investors" section of the Maravai web site at About Maravai Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical, vaccine, di

MRVI.O

Story updates

08:04:55 PM UTC
SquawkNews
Maravai LifeSciences to Host Third – Quarter Earnings Conference Call

For best results when printing this announcement, please click on link below: Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 4, 2026 Maravai LifeSciences, Inc. m. m. ET.

To participate in the conference call by telephone, dial 1-800-343-4849 or 1-203-518-9848 and reference Maravai LifeSciences, Conference ID: MARAVAI. The call will also be available via live or archived webcast on the "Investors" section of the Maravai web site at About Maravai Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases.

Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies. com)